GlassScriptPhysician profile
David Sustarsic
NPI 1134183130
$9,433.86
in general payments reported to CMS, 2019-2025
23 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,192 · 2020: $592 · 2021: $972 · 2022: $841 · 2023: $986 · 2024: $1,852.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,838.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,837.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $2,505.23 | 2019-2024 | Indigo System |
| Medtronic, INC. | $2,247.37 | 2021-2024 | Endurant Iis |
| W. L. Gore & Associates, INC. | $1,428.31 | 2019-2024 | Gore Viabahn Vbx Balloon Expandable Endo, Gore Viabahn Endoprosthesis With Heparin |
| Medtronic Vascular, INC. | $1,220.44 | 2019-2020 | |
| Boston Scientific Corporation | $955.57 | 2019-2024 | Opticross 35, Innova Vascular, Ranger |
| Tosoh Bioscience, INC. | $169.00 | 2019 | |
| Cvrx, INC. | $165.23 | 2024 | Barostim Neo System |
| Edwards Lifesciences Corporation | $144.91 | 2021 | |
| Abiomed | $114.42 | 2022 | |
| Shockwave Medical, INC | $94.95 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Amgen INC. | $75.42 | 2024 | |
| Merck Sharp & Dohme LLC | $45.12 | 2023 | Verquvo, Belsomra |
| Cordis US Corp. | $43.17 | 2022-2023 | Rain Sheath Transradial |
| Ge Healthcare | $43.11 | 2019 | |
| Abbott Laboratories | $41.45 | 2019-2022 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $33.91 | 2019 | |
| Novo Nordisk INC | $20.34 | 2024 | Ozempic |
| Teleflex LLC | $17.81 | 2019 | |
| Smith+Nephew, INC. | $17.24 | 2022 | |
| Welch Allyn | $14.08 | 2021 | |
| Janssen Pharmaceuticals, INC | $12.90 | 2019 | |
| Lemaitre Vascular, INC. | $12.13 | 2020 | |
| Artivion, INC. | $11.75 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Sustarsic listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.